Future of Uremic Toxin Management.

Area of Science:

• Nephrology
• Toxicology
• Internal Medicine

Background:

• Uremic toxins accumulate during chronic kidney disease (CKD) progression, driving uremic syndrome.
• Current management often focuses on dialysis, which has limitations for early-stage CKD and only partially mitigates toxicity.
• Advances in understanding uremic toxin effects have outpaced strategies for their reduction.

Purpose of the Study:

• To review emerging and established alternative methods for counteracting uremic toxicity in CKD.
• To highlight interventions beneficial in earlier stages of CKD, not just end-stage disease.
• To explore a range of therapeutic approaches, including dietary, pharmacological, and extracorporeal methods.

Main Methods:

• Literature review of recent research on uremic toxin management.
• Focus on non-dialysis interventions for CKD.
• Categorization of methods into kidney function preservation, cardiovascular protection, gastrointestinal interventions, and pharmacologic approaches.

Main Results:

• Established and experimental methods exist to reduce uremic toxin burden.
• Interventions targeting kidney function, cardiovascular health, gut microbiome, and pharmacotherapy show promise.
• Alternative extracorporeal methods for toxin removal are also under investigation.

Conclusions:

• There is a need for broader CKD treatment strategies beyond dialysis to address uremic toxicity.
• Alternative approaches offer potential benefits across various CKD stages.
• Further research and evidence-based assessment are crucial for developing sustainable CKD treatment models.